Melanocortin ligands and methods of use thereof
US10899793B2 · kind B2 · utility
3Cited by
11References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 25, 2017 |
| Grant date | Jan 26, 2021 |
| Priority date | — |
| Expiry date | Jul 30, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/575
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain embodiments of the invention provide a compound of formula (I): R1—C(═O)—W—X—Y—Z—N(R2)2 (I) or a salt thereof, wherein R1, R2, W, X, Y and Z are as defined herein, as well as methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.